-+ 0.00%
-+ 0.00%
-+ 0.00%

Purple Biotech Q3 EPADS $(0.29) Misses $(0.26) Estimate

Benzinga·11/14/2025 13:25:21
Listen to the news
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 25.64 percent increase over losses of $(0.39) per share from the same period last year.